Xerofung Cream contains Itraconazole 1% w/w, a broad-spectrum antifungal agent indicated for the topical treatment of various superficial fungal infections of the skin. Itraconazole belongs to the triazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. Xerofung Cream is effective against dermatophytes, yeasts, and molds responsible for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidiasis. The cream formulation facilitates targeted delivery of the active ingredient to the affected area, promoting rapid symptom relief including reduction of itching, scaling, and inflammation. Xerofung Cream should be applied topically to the affected area once or twice daily as directed by a healthcare professional, with treatment duration typically ranging from 2 to 4 weeks depending on the severity and type of infection. It is important to continue treatment for the full prescribed duration to prevent recurrence. Xerofung Cream is generally well tolerated; however, mild local adverse reactions such as burning, irritation, or redness may occur. Patients with known hypersensitivity to itraconazole or any component of the formulation should avoid use.